Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers
Experimental Dermatology · 2026
DOI: 10.1111/exd.70352 ↗At a glance
Journal article in Experimental Dermatology, 2026. Written by Linda T H Godding and 13 co-authors. Institution: Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands. Major MEDLINE topics: Biomarkers, Skin Diseases. 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (original language)
Successful implementation of dermatological biomarkers depends on early understanding of clinical needs and adoption barriers. Yet, research on these factors as perceived by dermatological care providers (DCPs) is scarce and perspectives of patients are largely underexplored. This survey study among patients and DCPs assessed biomarker needs and adoption barriers and facilitators for five inflammatory skin diseases: psoriasis (PsO), atopic dermatitis (AD), hidradenitis suppurativa (HS), cutaneous lupus erythematosus (CLE) and chronic spontaneous urticaria (CSU). In total, the study population consisted of 591 patients and 99 DCPs. Across all skin diseases, both groups mainly prioritized a biomarker for prediction of therapeutic response, however, DCPs prioritized this substantially more often than patients, especially for PsO (79.8% vs. 31.3% resp.), AD (68.7% vs. 37.1% resp.) and HS (66.7% vs. 34.4% resp.). Notably, a biomarker for the prediction of the risk to develop comorbidities was prioritized relatively often by patients (7.0%–19.4%), whereas DCPs only substantially prioritized this for CLE (14.1%). To enhance implementation, patients must ideally be able to undergo biomarker collection nearby their homes (travel time < 1 h) with complete reimbursement. For DCPs it is important that the biomarker is well validated, non‐invasive and measurable during regular visits with preferably a short sampling time.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Institute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.
- Lectoraat Human Communication Development, HAN University of Applied Sciences, Nijmegen, the Netherlands.
- Psoriasispatiënten Nederland (PN), Nijkerk, the Netherlands.
- Nationale vereniging voor mensen met lupus, APS, sclerodermie en MCTD (NVLE), Utrecht, the Netherlands.
- Centre for Human Drug Research (CHDR), Leiden, the Netherlands.
ORCID profiles: Linda T H Godding, Elke M G J de Jong, Sylvia van Beugen, Antoinette I M van Laarhoven, Robert Rissmann, Juul M P A van den Reek
Funding
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Cite
APA
Godding, L. T. H., de Jong, E. M. G. J., van Beugen, S., van Laarhoven, A. I. M., van der Pool, E., Olde, N. J., Trampe, D., Niehues, H., van Ee, I., Sluijmers, A., Rissmann, R., van den Reek, J. M. P. A., Seyger, M. M. B., & Next Generation ImmunoDermatology Consortium (NGID) (2026). Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers. Experimental Dermatology. https://doi.org/10.1111/exd.70352
Vancouver
Godding LTH, de Jong EMGJ, van Beugen S, van Laarhoven AIM, van der Pool E, Olde NJ, et al. Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers. Experimental Dermatology. 2026. doi:10.1111/exd.70352
BibTeX
@article{Godding2026,
author = {Godding, Linda T H and de Jong, Elke M G J and van Beugen, Sylvia and van Laarhoven, Antoinette I M and van der Pool, Els and Olde, Nanda J and Trampe, Debra and Niehues, Hanna and van Ee, Ilse and Sluijmers, Annemarie and Rissmann, Robert and van den Reek, Juul M P A and Seyger, Marieke M B and Next Generation ImmunoDermatology Consortium (NGID), Next Generation ImmunoDermatology Consortium (NGID)},
title = {Future Integration of Biomarkers for Inflammatory Skin Diseases Into Daily Practice: A Survey Among a Multifaceted Group of Patients and Dermatological Care Providers},
journal = {Experimental Dermatology},
year = {2026},
doi = {10.1111/exd.70352}
}
EUVIMED